| Protocol ID |
|
Title |
|
|
| In house-MRI |
|
Investigation of the Utility of Advanced MRI Imagine Methods for Radiation Therapy Treatment Planning
Keywords: Advanced MRI Imagine Methods for Radiation Therapy Treatment Planning (Brain, Breast, Head & Neck, Lung, Cervix, Sacroma, Prostate, or Liver and Liver Mets) |
|
| E1208 |
|
A Phase III Randomized, Double-Blind Trial of Chemoembolization with or without Sorafenib in E1208: Unresectable Hepatocellular Carcinoma (HCC) in Patients with and Without Vascular Invasion
Keywords: Unresectable Hepatocellular Carcinoma (HCC) in Patients with and Without Vascular Invasion |
|
| Industry-pancreas |
|
A Global, Multi-Center, Open Label, Phase II Study of AGS-1C4D4 Given in Combination with Gemcitabine in Subjects with Metastatic Pancreatic Cancer
Keywords: Metastatic Pancreatic Cancer |
|
| S0809 |
|
A Phase II Trial of Adjuvant Capecitabine/ Gemcitabine Chemotherapy Followed by Concurrent Capecitabine and Radiotherapy in Extrahepatic Cholangiocarcinoma (EHCC)
Keywords: Extrahepatic Cholangiocarcinoma |
|
| ACOSOG Z5041 |
|
A Phase II Study of Preoperative Gemcitabine and Erlotinib Plus Pancreatectomy and Postoperative Gemcitabine and Erlotinib for Patients with Operable Pancreatic Adenocarcinoma
Keywords: Operable Pancreatic Adenocarcinoma |
|
| In-House |
|
Prospective Collection of Pancreatic Fluid and Tissue by Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) for Molecular Analysis
Keywords: Collection of Pancreatic Fluid for Molecular Analysis |
|
| In House-database |
|
Hepato-pancreatico-biliary (HPB) Clinical Database
Keywords: HPB clinical database |
|
| In-House-QOL |
|
Quality of Life Assessment for Adenocarcinoma of the Pancreatic Head
Keywords: quality of life assessment |
|
| In-House- tissue bank |
|
Tissue Bank, Pilot for the MCW Tissue Banking Program
Keywords: tissue bank |
|
| RTOG0848 |
|
A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
Keywords: Patients with Resected Head of Pancreas Adenocarcinoma |
|
NSABP FC-6
Also in (GI) |
|
A Phase II Study to Determine the Surgical Conversion Rate in Patients Receiving Neoadjuvant mFOLFOX7 Plus Cetuximab for Unresectable Wild-Type K-RAS Colorectal Cancer with Metastases Confined to the Liver
Keywords: Colorectal Cancer with Metastases Confined to the Liver |
|
| DEBIRI (also in GI) |
|
Precision Irinotecan Therapy of Liver Metastasis from Colon Cancer with Concomitant Systematic Oxaliplatin, Fluorouracil and Leucovorin Chemotherapy and Avastin Therapy
Keywords: Liver Metastasis from Colon Cancer |
|
| Industry-hepatic registry |
|
Hepatic Research Registry
Keywords: hepatic registry |
|
| CO-1.01 |
|
A Phase II Randomized, Open-Label, Multicenter Study Comparing CO-1.01 with Gemcitabine as First Line Therapy in Patients with Metastatic Pancreatic Adenocarcinoma
Keywords: Metastatic Pancreatic Adenocarcinoma |
|
| CP12-0919 |
|
A Multicenter, Randomized, Double-Blind, Phase III Study of Ramucirumab (IMC-1121B) Drug Product and Best Supportive Care (BSC) v. Placebo and BSC as Second Line Treatment in Patients with Hepatocellular Carcinoma Following First-Line Therapy with Sorafenib
Keywords: Patients with Hepatocellular Carcinoma |
|
| Industry (Also in GI) |
|
Randomized Comparative Study of FOLFOX 6m Plus Sir-Spheres Microspheres v. FOLFOX 6m Alone as First Line Treatment in Patients with Nonresectable Liver Metastases from Primary Colorectal Carcinoma
Keywords: Nonresectable Liver Metastases from Primary Colorectal Carcinoma |
|
| In-house- Pancreas |
|
A Prospective, Phase II Trial of Molecular Profiling to Guide Neoadjuvant Therapy for Resectable and Borderline Resectable Adenocarcinoma of the Pancreatic Head, Neck or Uncinate Process
Keywords:Resectable and Borderline Resectable Adenocarcinoma |
|
| Industry-003 |
|
A Phase II, Open-Label, Multi-Center Study to Evaluate the Anti-tumor Efficacy of C0-1.01 for Infusion as Second Line Therapy for Gemcitabine-Refractory Patients with Stage IV Pancreatic Adenocarcinoma and No Tumor hENT1 Expression
Keywords:Stage IV Pancreatic Adenocarcinoma |